Taking Parkinson’s education to the farmers market: educating under-served communities Posted on September 16, 2019September 16, 2019 by Phil Franchina Taking Parkinson’s education to the farmers market: educating under-served communities Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian Medical Center in New York City, attended APDA’s Diversity in Parkinson’s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi had just spent the day learning about health care disparities in PD care, low […] Read More
APDA ANNOUNCES $1.7 MILLION IN NEW PARKINSON’S DISEASE RESEARCH GRANTS. FUNDING ENABLES 10 RESEARCHERS TO CONDUCT IMPACTFUL RESEARCH. Posted on September 10, 2019 by Dr. Rebecca Gilbert APDA announces funding for 2019-2020 grants It is that time of year – when APDA announces our research grantees for the 2019-2020 fiscal year. We are very proud of our grant recipients who each has a unique idea that will hopefully benefit the entire Parkinson’s disease (PD) community. This year APDA has awarded $1.7 million […] Read More
New medication, Istradefylline, gets approved for Parkinson’s disease Posted on September 4, 2019 by Stephanie Paul New medication, Istradefylline, gets approved for Parkinson’s disease On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […] Read More
APDA Seed Funding Leads to Prestigious NIH Research Grant Posted on August 16, 2019August 16, 2019 by Stephanie Paul APDA Seed Funding Leads to Prestigious NIH Research Grant APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research Grant awardee on receiving a recently-awarded National Institutes of Health (NIH) R21 grant. Read More
APDA-funded research finds new role for alpha-synuclein Posted on July 30, 2019July 31, 2019 by Stephanie Paul APDA-funded research finds new role for alpha-synuclein This new understanding of alpha-synuclein’s function could open up new ways of thinking about treatments for Parkinson’s disease. Read More
Fighting Parkinson’s Disease Around the World – Highlights from the World Parkinson Congress Posted on June 25, 2019June 25, 2019 by Guest Author Fighting Parkinson’s Disease Around the World – Highlights from the World Parkinson Congress APDA was in Kyoto for the 5th WPC — an international forum for dialogue on the latest scientific discoveries, medical practices, and caregiver initiatives. Read More
$52 billion per year is spent on PD-related expenses, according to results of the Economic Burden of Parkinson’s Disease Study Posted on June 13, 2019June 14, 2019 by Dr. Rebecca Gilbert $52 billion per year is spent on PD-related expenses, according to results of the Economic Burden of Parkinson’s Disease Study In October 2018, APDA asked our constituents to consider participating in a new study called The Economic Burden of Parkinson’s Disease (PD), with the goal of estimating the economic burden of PD in the United […] Read More
APDA’s Diversity in Parkinson’s Disease Research Conference 2019 Posted on June 3, 2019June 5, 2019 by Dr. Rebecca Gilbert APDA’s Diversity in Parkinson’s Disease Research Conference 2019 APDA held the first Diversity in Parkinson’s Disease Research Conference. on 5/17/19 to address urgent needs surrounding PD in diverse, under-served communities. Read More
American Academy of Neurology Annual Meeting 2019 – Highlights Posted on May 14, 2019May 14, 2019 by Dr. Rebecca Gilbert American Academy of Neurology Annual Meeting 2019 – Highlights Our team shares 12 highlights related to Parkinson’s research from the 2019 American Academy of Neurology Meeting. Read More
APDA attends the International Congress of Parkinson’s disease and Movement disorders Posted on October 16, 2018April 29, 2019 by Dr. Rebecca Gilbert APDA attends the International Congress of Parkinson’s disease and Movement disorders Dr. Gilbert describes the International Congress of Parkinson’s disease and Movement disorders Read More
